Welcome
Emphasis is given to the cross-national/comparative aspects of industry structure and evolution, differences in health care systems, diversity in tradition of university-industry relationships, and the divergent growth rates of small biotech/drug discovery companies in US vs. Europe. Use the navigation buttons to browse this web site.
The main objective of EPRIS is to develop a comprehensive analysis of the structure and evolution of the European Pharmaceutical Regulation and Innovation Systems.